U.S. Oil and Gas Stock News

AbbVie recently announced that the European Commission approved RINVOQ (upadacitinib, 15 mg once daily) as the first systemic therapy in the EU for non-segmental vitiligo in patients 12 years and older who are candidates for systemic treatment. This decision expands AbbVie’s immunology footprint into an area of high unmet need, potentially enhancing the clinical and commercial profile of RINVOQ across dermatology. We’ll now examine how RINVOQ’s new European non-segmental vitiligo approval...

UnitedHealth Group has delivered a strong 68.6% return over the past year, yet its valuation checks point to a more mixed picture rather than a clear bargain or an obviously stretched stock. Over the last 12 months, the stock is up 68.6%, which puts recent buyers in a comfortable position and raises the bar for what counts as good value from here. Recent coverage has highlighted improved profitability and operational efficiencies as potential supports for earnings, while ongoing shifts in...

Liberty Latin America stock has delivered a 24.0% gain over the past year but is still down 37.7% over five years, which raises the question of whether the recent recovery is finally bringing the share price closer to what its fundamentals suggest. Over the last five years the stock has declined 37.7%, which indicates long term holders have not yet recovered from earlier share price weakness. The recent agreement to sell its stake in Peru based WOW Tel S.A.C. can help Liberty Latin America...

In the second quarter of 2026, Southwest Airlines Co. reported revenue of US$8,432 million and net income of US$233 million, with both figures higher than a year earlier, alongside improved earnings per share. Over the first half of 2026, Southwest’s net income rose to US$460 million from US$64 million, highlighting a much stronger earnings profile while the company simultaneously completed a multi‑year share repurchase program totaling 37,538,504 shares for US$1,550.06 million. We’ll now...

Bloom Energy reported record second-quarter 2026 results, with revenue rising to about US$1.07 billion from US$401.24 million a year earlier and net income improving to US$196.29 million, while also raising its full-year 2026 revenue outlook to US$3.9 billion–US$4.2 billion. The company underscored rapidly growing demand from AI and hyperscale data centers and expanded its Brookfield financing framework to up to US$25.00 billion, highlighting how large capital commitments are supporting its...

In recent months, BWX Technologies has expanded its precision nuclear manufacturing capacity through acquisition while reporting rapidly rising year-over-year sales and improved free cash flow margins, supported by growing AI-related demand for nuclear power. This combination of stronger operating cash generation and a larger production footprint suggests BWX Technologies may now have greater flexibility to fund future nuclear-related projects or shareholder returns. We’ll now examine how...

Pfizer stock sits in an awkward middle ground today. The shares have fallen about 28% over the past five years, yet recent gains and a mixed valuation score suggest the market now sees the stock as closer to fairly priced than a clear bargain. Pfizer has declined roughly 28% over five years, which raises the question of whether the recent share price better reflects its longer term prospects or still embeds caution. Priority review for the TALZENNA plus XTANDI prostate cancer treatment can...

While it’s been a great week for Bankwell Financial Group, Inc. ( NASDAQ:BWFG ) shareholders after stock gained 11...

Goodyear Tire & Rubber (GT) is drawing fresh attention after recent commentary highlighted ongoing annual sales declines, shareholder dilution from new stock issuance, and continued cash burn, all of which are weighing on confidence in the company’s long term growth prospects. See our latest analysis for Goodyear Tire & Rubber. Recent trading has been mixed for Goodyear Tire & Rubber, with a 30 day share price return of 7.6% and a 90 day gain of 4.4%. However, the year to date share price...

AI is no longer just a big tech story. It now sits at the crossroads of inflation debates, interest rate decisions, and shifting credit conditions across the US, Europe, and Asia. As central banks weigh wage growth, energy costs, and housing signals, investors are looking for growth that is less tied to broad market indices and more to real adoption of machine learning, automation, and data intelligence. This article focuses on AI Small Caps, where early-stage ideas can still move the needle...

Enerpac Tool Group (EPAC) recently attracted investor attention after its board declared an annual cash dividend of $0.04 per share and approved a leadership change in the principal accounting officer role. See our latest analysis for Enerpac Tool Group. Recent news around Enerpac Tool Group, including the dividend declaration and the upcoming Investor Day at the New York Stock Exchange on 4 November 2026, comes as momentum has picked up again. The share price is at US$37.09, with a 1 day...

Ashland (ASH) is back in focus after reporting third quarter fiscal 2026 results, reaffirming full year sales guidance and unveiling board changes tied to a cooperation agreement with stockholder Ancora Holdings Group. See our latest analysis for Ashland. Following the earnings release and board changes, Ashland's recent momentum stands out, with a 90 day share price return of 38.37% and a 1 year total shareholder return of 39.55% indicating improving sentiment compared with weaker multi year...

Fortrea Holdings, a clinical research company, recently announced it would release earnings after previously posting quarterly revenue of US$636.5 million, a 2.3% decline year on year that still surpassed analyst expectations. Investor attention is now centered on whether Fortrea can again outperform consensus as the market anticipates an 8.8% year-on-year revenue decline this quarter, reversing last year's growth in the same period. Next, we'll explore how this anticipated revenue decline,...

Vicor stock has delivered a very strong 320.2% return over the past year, yet the current checks on valuation suggest a company that no longer looks obviously cheap. The Discounted Cash Flow (DCF) intrinsic value estimate points to pricing that is roughly in line with fundamentals, while the broader valuation score leans more cautious. Over the past 12 months, Vicor has returned 320.2%, which puts extra focus on whether recent gains are already pricing in a lot of good news. Growing demand...

Some CSX Corporation ( NASDAQ:CSX ) shareholders may be a little concerned to see that the VP & Chief Accounting...

Looking at Carriage Services, Inc.'s ( NYSE:CSV ) insider transactions over the last year, we can see that insiders...

We wouldn't blame The Progressive Corporation ( NYSE:PGR ) shareholders if they were a little worried about the fact...

AMREP Corporation ( NYSE:AXR ), might not be a large cap stock, but it saw significant share price movement during...

Some Roper Technologies, Inc. ( NASDAQ:ROP ) shareholders may be a little concerned to see that the Independent...

In late July 2026, Mercury Insurance released its annual list of the 10 most affordable new 2026 model year SUVs to insure, underscoring how vehicle choice can meaningfully affect long-term insurance costs. Analyst commentary around the same time characterized Mercury General as a strong growth candidate with favourable earnings prospects, drawing attention to how shifting expectations and estimate revisions can reshape perceptions of an insurer’s future earnings power. We’ll now examine...

Carvana (CVNA) has expanded its same day vehicle delivery service to the greater Fort Myers area, giving local customers faster access to online purchases and same day options for selling or trading in vehicles. See our latest analysis for Carvana. The latest product rollout comes after a mixed period for Carvana’s stock, with the 1 day share price return of 3.17% and 1 month share price return of 5.97% contrasting with a year to date decline of 17.46% and a much stronger 3 year total...

Hexcel’s share price has more than doubled over the past five years, yet valuation checks send mixed signals, with a Discounted Cash Flow (DCF) intrinsic value suggesting the stock trades below its estimated worth while market multiples point to a richer price tag. Hexcel has returned 105.9% over five years, which puts extra focus on whether the current price still offers a margin between market value and the intrinsic estimate. The recent NCAMP qualification of the HexPly M91 composite...

Conagra Brands stock has fallen about 43.8% over the past three years, yet on Simply Wall St's checks it still screens as relatively cheap overall, while the share price now looks closer to fair on standard market multiples. With management resetting the dividend and committing extra supply chain investment, investors are weighing whether the current price fairly reflects those trade offs. The roughly 43.8% share price decline over three years points to weak recent returns and a market that...

Ascendis Pharma (NasdaqGS:ASND) has drawn fresh investor attention after recent trading left the stock around $254.44, with short term returns mixed over the past week, month and past three months. See our latest analysis for Ascendis Pharma. Over a longer stretch, Ascendis Pharma has seen a 10.93% 90 day share price return and a 3.69% year to date share price return. The recent 30 day decline of 3.51% suggests some of that momentum has cooled even as the stock holds near US$254.44. If this...